Organ Transplantation: A Comprehensive Overview

Organ transplantation is a medical procedure where an organ is removed from one body and placed in another to replace a damaged or missing organ. Organs can be transported from a donor site to another location within the same person's body (autografts), or between two individuals of the same species (allografts). Allografts can be from living or deceased donors.

Successful organ transplants include the heart, kidneys, liver, lungs, pancreas, intestine, and thymus. Tissues such as bones, tendons (musculoskeletal grafts), corneas, skin, heart valves, nerves, and veins are also transplanted. Globally, kidneys are the most commonly transplanted organs, followed by the liver and heart. Corneas and musculoskeletal grafts are the most common tissues, significantly outnumbering organ transplants.

Organ donors can be living, brain dead, or dead via circulatory death. Tissue can be recovered from donors who die of circulatory death or brain death, up to 24 hours after heartbeat cessation. Unlike organs, most tissues, excluding corneas, can be preserved and stored for up to five years, allowing for 'banking'.

Transplantation raises numerous bioethical issues, including the definition of death, consent procedures for organ donation, and financial aspects. Other ethical concerns include transplantation tourism and the socio-economic context of organ procurement and transplantation. Organ trafficking remains a significant problem.

Transplantation medicine is a challenging and complex field. Managing transplant rejection, where the body's immune system attacks the transplanted organ, is crucial. Transplant rejection can be minimized through serotyping to find the best donor-recipient match and using immunosuppressant drugs.

Types of Transplant

1. Autograft: Transplantation of tissue within the same person. This may involve surplus tissue, regenerative tissue, or tissue needed elsewhere. Examples include skin grafts, vein extraction for CABG, stem cell autografts, and storing blood before surgery.

2. Allograft and Allotransplantation: Transplantation of an organ or tissue between two genetically non-identical individuals of the same species. Most human tissue and organ transplants are allografts. Due to genetic differences, the recipient's immune system may reject the organ. Isografts, a subset of allografts, involve transplantation from a genetically identical donor (e.g., an identical twin). Isografts do not trigger an immune response.

3. Xenograft and Xenotransplantation: Transplantation of organs or tissue from one species to another. Examples include porcine heart valve transplants and piscine-primate islet tissue transplants. Xenotransplantation is risky due to non-compatibility, rejection, and potential disease transmission.

4. Domino Transplants: In cases like cystic fibrosis, where both lungs need replacement, replacing both the heart and lungs with donor organs is easier and more successful. The recipient's healthy heart can then be transplanted into another recipient, making the cystic fibrosis patient a living heart donor.

Another example is a special liver transplant for familial amyloidotic polyneuropathy, where the recipient's liver is transplanted into an older patient. This also refers to a series of living donor transplants where one donor's organ facilitates multiple transplants, overcoming blood type or antibody barriers. This allows multiple recipients to receive transplants, even if their own living donor is not a match. Johns Hopkins Medical Center and Northwestern Memorial Hospital are pioneers in this type of transplantation.

Types of Donor

Organ donors can be living or deceased (brain dead or circulatory death). Most deceased donors are brain dead, meaning the cessation of brain function. Breathing is maintained through artificial means, which also sustains the heartbeat. Brain death criteria vary.

1. Living Donor: The donor remains alive and donates renewable tissue, cells, or fluids (e.g., blood, skin) or an organ that can regenerate or compensate for the lost portion (e.g., kidney, part of the liver). Regenerative medicine holds promise for laboratory-grown organs using the patient's own cells via stem cells.

2. Deceased Donor: Deceased donors have been declared brain-dead and their organs are kept viable by ventilators until they can be removed. Apart from brain-stem dead donors, donation-after-circulatory-death-donors are increasingly used to expand the donor pool. These organs have lower success rates than those from brain-dead donors, but given the scarcity of suitable organs, they remain a valuable option.

Allocation of Donated Organs

Most countries face a shortage of suitable organs for transplantation. Formal systems manage organ donor identification and allocation to recipients.

In the United States, the majority of deceased-donor organs are allocated by the Organ Procurement and Transplantation Network (OPTN), managed by the United Network for Organ Sharing (UNOS). Regional organ procurement organizations (OPOs), members of the OPTN, identify suitable donors and collect organs. UNOS then allocates organs using a scientifically driven and fair method.

The allocation methodology varies depending on the organ and is subject to periodic review. For kidneys, waiting time is a major factor. For livers, the Model of End-Stage Liver Disease (MELD) score, based on lab values indicating liver disease severity, is used.

Directed or targeted donation, where a deceased donor's family requests a specific recipient for an organ, is gaining popularity but remains rare. If medically suitable, the allocation system can be bypassed to fulfill the family's request. However, this is an exception to the general allocation process.

The allocation of deceased-donor organs in the United States is governed by established protocols to ensure fairness, transparency, and optimal outcomes for transplant recipients.